| # | Drug | Count |
|---|---|---|
| 0 | NIRMATRELVIR AND RITONAVIR | 22833 |
| 1 | OCRELIZUMAB | 11587 |
| 2 | PREDNISONE | 9598 |
| 3 | ADALIMUMAB | 9353 |
| 4 | ACETAMINOPHEN | 8686 |
| 5 | DUPILUMAB | 7649 |
| 6 | RITUXIMAB | 6971 |
| 7 | LENALIDOMIDE | 6619 |
| 8 | METHOTREXATE SODIUM | 6102 |
| 9 | ASPIRIN | 5684 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NIRMATRELVIR AND RITONAVIR | 22833 | 0.4232 |
| 1 | TETRAHYDROZOLINE HYDROCHLORIDE | 86 | 0.2925 |
| 2 | ESTRIOL | 391 | 0.2133 |
| 3 | OCRELIZUMAB | 11587 | 0.1847 |
| 4 | EPINEPHRINE HYDROCHLORIDE | 81 | 0.1709 |
| 5 | HUMAN IMMUNOGLOBULIN G | 2175 | 0.1039 |
| 6 | VELAGLUCERASE ALFA | 167 | 0.0814 |
| 7 | MINERAL OIL | 112 | 0.0755 |
| 8 | ALBENDAZOLE | 142 | 0.0746 |
| 9 | REMDESIVIR | 919 | 0.0691 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 21424 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 21237 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 15249 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 12966 |
| 4 | Thalidomide Analog [EPC] | 8315 |
| 5 | Interleukin-4 Receptor alpha Antagonist [EPC] | 7649 |
| 6 | Provitamin D2 Compound [EPC] | 7118 |
| 7 | Kinase Inhibitor [EPC] | 6626 |
| 8 | Proton Pump Inhibitor [EPC] | 6208 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 5829 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 850 | 1.2355 |
| 1 | Provitamin D2 Compound [EPC] | 7118 | 0.2392 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 1303 | 0.2226 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 349 | 0.1682 |
| 4 | Human Immunoglobulin G [EPC] | 2978 | 0.1414 |
| 5 | Interleukin-17A Antagonist [EPC] | 4913 | 0.1318 |
| 6 | CXC Chemokine Receptor 4 Antagonist [EPC] | 1 | 0.1250 |
| 7 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 919 | 0.0691 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 21237 | 0.0670 |
| 9 | Plasma Kallikrein Inhibitor [EPC] | 140 | 0.0584 |